Bambino Agro Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 27, 2025, 12:33 pm

Competitors of Bambino Agro Industries Ltd

All Competitor Stocks of Bambino Agro Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:40 pm

Below is a detailed analysis of the quarterly data for Bambino Agro Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 88.26 Cr.. The value appears to be declining and may need further review. It has decreased from 92.34 Cr. (Mar 2025) to 88.26 Cr., marking a decrease of 4.08 Cr..
• For Expenses, as of Jun 2025, the value is 79.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 87.08 Cr. (Mar 2025) to 79.14 Cr., marking a decrease of 7.94 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.12 Cr.. The value appears strong and on an upward trend. It has increased from 5.26 Cr. (Mar 2025) to 9.12 Cr., marking an increase of 3.86 Cr..
• For OPM %, as of Jun 2025, the value is 10.33%. The value appears strong and on an upward trend. It has increased from 5.70% (Mar 2025) to 10.33%, marking an increase of 4.63%.
• For Other Income, as of Jun 2025, the value is 0.10 Cr.. The value appears to be declining and may need further review. It has decreased from 0.15 Cr. (Mar 2025) to 0.10 Cr., marking a decrease of 0.05 Cr..
• For Interest, as of Jun 2025, the value is 2.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.67 Cr. (Mar 2025) to 2.80 Cr., marking an increase of 0.13 Cr..
• For Depreciation, as of Jun 2025, the value is 1.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.43 Cr. (Mar 2025) to 1.47 Cr., marking an increase of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.95 Cr.. The value appears strong and on an upward trend. It has increased from 1.31 Cr. (Mar 2025) to 4.95 Cr., marking an increase of 3.64 Cr..
• For Tax %, as of Jun 2025, the value is 27.88%. The value appears to be increasing, which may not be favorable. It has increased from 21.37% (Mar 2025) to 27.88%, marking an increase of 6.51%.
• For Net Profit, as of Jun 2025, the value is 3.57 Cr.. The value appears strong and on an upward trend. It has increased from 1.04 Cr. (Mar 2025) to 3.57 Cr., marking an increase of 2.53 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.46. The value appears strong and on an upward trend. It has increased from 1.30 (Mar 2025) to 4.46, marking an increase of 3.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:49 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: October 10, 2025, 3:35 pm

Below is a detailed analysis of the balance sheet data for Bambino Agro Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 8.00 Cr..
• For Borrowings, as of Mar 2025, the value is 100.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 85.00 Cr. (Mar 2024) to 100.00 Cr., marking an increase of 15.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 22.00 Cr.. The value appears to be improving (decreasing). It has decreased from 28.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 223.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 206.00 Cr. (Mar 2024) to 223.00 Cr., marking an increase of 17.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 15.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2024) to 121.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 223.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Mar 2024) to 223.00 Cr., marking an increase of 17.00 Cr..

However, the Borrowings (100.00 Cr.) are higher than the Reserves (93.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bambino Agro Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has decreased from 13.65 (Mar 24) to 11.51, marking a decrease of 2.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has decreased from 13.65 (Mar 24) to 11.51, marking a decrease of 2.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.18. This value is within the healthy range. It has decreased from 19.80 (Mar 24) to 18.18, marking a decrease of 1.62.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.33. It has increased from 116.43 (Mar 24) to 126.33, marking an increase of 9.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.33. It has increased from 116.43 (Mar 24) to 126.33, marking an increase of 9.90.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.60. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 458.98. It has increased from 415.11 (Mar 24) to 458.98, marking an increase of 43.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 34.93. This value is within the healthy range. It has increased from 34.37 (Mar 24) to 34.93, marking an increase of 0.56.
• For PBIT / Share (Rs.), as of Mar 25, the value is 28.25. This value is within the healthy range. It has increased from 28.21 (Mar 24) to 28.25, marking an increase of 0.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.43. This value is within the healthy range. It has decreased from 18.22 (Mar 24) to 17.43, marking a decrease of 0.79.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has decreased from 13.65 (Mar 24) to 11.51, marking a decrease of 2.14.
• For PBDIT Margin (%), as of Mar 25, the value is 7.61. This value is below the healthy minimum of 10. It has decreased from 8.27 (Mar 24) to 7.61, marking a decrease of 0.66.
• For PBIT Margin (%), as of Mar 25, the value is 6.15. This value is below the healthy minimum of 10. It has decreased from 6.79 (Mar 24) to 6.15, marking a decrease of 0.64.
• For PBT Margin (%), as of Mar 25, the value is 3.79. This value is below the healthy minimum of 10. It has decreased from 4.38 (Mar 24) to 3.79, marking a decrease of 0.59.
• For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has decreased from 3.28 (Mar 24) to 2.50, marking a decrease of 0.78.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 15. It has decreased from 11.72 (Mar 24) to 9.10, marking a decrease of 2.62.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.98. This value is within the healthy range. It has decreased from 17.20 (Mar 24) to 16.98, marking a decrease of 0.22.
• For Return On Assets (%), as of Mar 25, the value is 4.12. This value is below the healthy minimum of 5. It has decreased from 5.29 (Mar 24) to 4.12, marking a decrease of 1.17.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.32 (Mar 24) to 0.22, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.89. This value is within the healthy range. It has increased from 0.74 (Mar 24) to 0.89, marking an increase of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.71. It has increased from 1.63 (Mar 24) to 1.71, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.42 (Mar 24) to 1.35, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.35, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 4. It has increased from 1.91 (Mar 24) to 2.10, marking an increase of 0.19.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.72 (Mar 24) to 0.00, marking a decrease of 11.72.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.08 (Mar 24) to 0.00, marking a decrease of 8.08.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.28 (Mar 24) to 0.00, marking a decrease of 88.28.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.92 (Mar 24) to 0.00, marking a decrease of 91.92.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.23. This value is within the healthy range. It has decreased from 3.44 (Mar 24) to 3.23, marking a decrease of 0.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 3. It has decreased from 2.37 (Mar 24) to 2.06, marking a decrease of 0.31.
• For Enterprise Value (Cr.), as of Mar 25, the value is 344.47. It has increased from 336.26 (Mar 24) to 344.47, marking an increase of 8.21.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.01 (Mar 24) to 0.93, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 12.31. This value is within the healthy range. It has increased from 12.22 (Mar 24) to 12.31, marking an increase of 0.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.69, marking a decrease of 0.11.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.27 (Mar 24) to 0.00, marking a decrease of 88.27.
• For Price / BV (X), as of Mar 25, the value is 2.52. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.52, marking a decrease of 0.35.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.69, marking a decrease of 0.11.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness